Heart Risks Are Similar With Human and Analogue Insulin, at Least Initially
Heart Risks Are Similar With Human and Analogue Insulin at Least Initially.jpg

People with type 2 diabetes who start taking insulin to manage their blood sugar may have a similarly low risk of developing or dying from cardiovascular problems regardless of the type of insulin they use, a new study suggests.

$5.6 million awarded to Kaiser Permanente researcher to study treatments for type 2 diabetes

A research team led by Romain S. Neugebauer, PhD, an investigator at the Kaiser Permanente Northern California Division of Research, and Patrick O’Connor, MD, an investigator at HealthPartners Institute, received a $5.6 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to study the benefits — and potential harms — on heart health of the second-line medications used to treat type 2 diabetes.

Food banks tackling diabetes? Feeding America releases pilot intervention results
Food banks tackling diabetes Feeding America releases pilot intervention results.jpg

Food banks can improve food security, dietary intake and health status for vulnerable individuals, such as those with diabetes Type 2, according to a new report from Feeding America. 

The aim of this Center is to actively foster and support translational research in diabetes within health care delivery systems affiliated with the Health Care System Research Network (HCSRN) and the University of California San Francisco.

This center addresses three translational research core areas to improve diabetes care:

  • Health Care Disparities
  • Diabetes and Obesity Prevention
  • Health Information Technology Interventions

This center also supports a national resource to improve diabetes prevention and care.


This center is funded by P30DK092924